Literature DB >> 30649388

Utility of the PROMIS Pediatric Pain Interference Scale in Juvenile Fibromyalgia.

Lauren M Fussner1, William R Black1, Anne Lynch-Jordan1, Esi M Morgan2, Tracy V Ting2, Susmita Kashikar-Zuck1.   

Abstract

OBJECTIVE: The current study tested the utility of the PROMIS Pediatric Pain Interference (PPI) in relation to the widely-used Functional Disability Inventory (FDI) in a small-scale clinical trial.
METHODS: Forty youth with juvenile fibromyalgia (JFM) were randomized to either CBT only or a combined CBT and neuromuscular exercise group (i.e., FIT Teens). Participants completed the PPI and FDI at baseline, post-treatment, and three-month follow-up.
RESULTS: The PPI and FDI were significantly correlated at baseline (r = .51) and post treatment (r = .53), and demonstrated similar improvements (d PPI = .87, d FDI = 1.22, p < .05) at post-treatment following FIT Teens. Following CBT only, neither the PPI nor the FDI improved significantly.
CONCLUSIONS: The PPI may be appropriate for use in non-pharmacologic interventions for pediatric pain.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Society of Pediatric Psychology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  PROMIS; fibromyalgia; functional impairment; pain interference; pediatric pain

Mesh:

Year:  2019        PMID: 30649388      PMCID: PMC6481384          DOI: 10.1093/jpepsy/jsy110

Source DB:  PubMed          Journal:  J Pediatr Psychol        ISSN: 0146-8693


  19 in total

Review 1.  Systematic review of the psychometric properties, interpretability and feasibility of self-report pain intensity measures for use in clinical trials in children and adolescents.

Authors:  Jennifer N Stinson; Tricia Kavanagh; Janet Yamada; Navreet Gill; Bonnie Stevens
Journal:  Pain       Date:  2006-06-13       Impact factor: 6.961

2.  Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS).

Authors:  Bryce B Reeve; Ron D Hays; Jakob B Bjorner; Karon F Cook; Paul K Crane; Jeanne A Teresi; David Thissen; Dennis A Revicki; David J Weiss; Ronald K Hambleton; Honghu Liu; Richard Gershon; Steven P Reise; Jin-shei Lai; David Cella
Journal:  Med Care       Date:  2007-05       Impact factor: 2.983

3.  PROMIS pediatric measures in pediatric oncology: valid and clinically feasible indicators of patient-reported outcomes.

Authors:  Pamela S Hinds; Suzanne L Nuss; Kathleen S Ruccione; Janice S Withycombe; Shana Jacobs; Holly DeLuca; Charisse Faulkner; Yang Liu; Yao I Cheng; Heather E Gross; Jichuan Wang; Darren A DeWalt
Journal:  Pediatr Blood Cancer       Date:  2012-07-24       Impact factor: 3.167

4.  Pilot Randomized Trial of Integrated Cognitive-Behavioral Therapy and Neuromuscular Training for Juvenile Fibromyalgia: The FIT Teens Program.

Authors:  Susmita Kashikar-Zuck; William R Black; Megan Pfeiffer; James Peugh; Sara E Williams; Tracy V Ting; Staci Thomas; Katie Kitchen; Gregory D Myer
Journal:  J Pain       Date:  2018-04-17       Impact factor: 5.820

5.  Clinical utility and validity of the Functional Disability Inventory among a multicenter sample of youth with chronic pain.

Authors:  Susmita Kashikar-Zuck; Stacy R Flowers; Robyn Lewis Claar; Jessica W Guite; Deirdre E Logan; Anne M Lynch-Jordan; Tonya M Palermo; Anna C Wilson
Journal:  Pain       Date:  2011-03-31       Impact factor: 6.961

6.  PROMIS(®) pediatric self-report scales distinguish subgroups of children within and across six common pediatric chronic health conditions.

Authors:  Darren A DeWalt; Heather E Gross; Debbie S Gipson; David T Selewski; Esi Morgan DeWitt; Carlton D Dampier; Pamela S Hinds; I-Chan Huang; David Thissen; James W Varni
Journal:  Qual Life Res       Date:  2015-02-26       Impact factor: 4.147

7.  Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations.

Authors:  Patrick J McGrath; Gary A Walco; Dennis C Turk; Robert H Dworkin; Mark T Brown; Karina Davidson; Christopher Eccleston; G Allen Finley; Kenneth Goldschneider; Lynne Haverkos; Sharon H Hertz; Gustaf Ljungman; Tonya Palermo; Bob A Rappaport; Thomas Rhodes; Neil Schechter; Jane Scott; Navil Sethna; Ola K Svensson; Jennifer Stinson; Carl L von Baeyer; Lynn Walker; Steven Weisman; Richard E White; Anne Zajicek; Lonnie Zeltzer
Journal:  J Pain       Date:  2008-06-17       Impact factor: 5.820

8.  Temperament and stress response in children with juvenile primary fibromyalgia syndrome.

Authors:  Paola M Conte; Gary A Walco; Yukiko Kimura
Journal:  Arthritis Rheum       Date:  2003-10

9.  Normative and reliability data for the Children's Depression Inventory.

Authors:  M R Smucker; W E Craighead; L W Craighead; B J Green
Journal:  J Abnorm Child Psychol       Date:  1986-03

10.  Depression, coping, and functional disability in juvenile primary fibromyalgia syndrome.

Authors:  Susmita Kashikar-Zuck; Michelle H Vaught; Kenneth R Goldschneider; Thomas B Graham; Jonathan C Miller
Journal:  J Pain       Date:  2002-10       Impact factor: 5.820

View more
  1 in total

1.  Establishing Clinical Cut-points on the Pediatric PROMIS-Pain Interference Scale in Youth With Abdominal Pain.

Authors:  Kaitlyn L Gamwell; Constance A Mara; Kevin A Hommel; Susmita Kashikar-Zuck; Natoshia R Cunningham
Journal:  Clin J Pain       Date:  2021-12-17       Impact factor: 3.442

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.